PMVP

PMV Pharmaceuticals Inc Cross-source read$1.40 2.78%
Health CareCUSIP 69353Y103· EOD Sep 11, 2026

Among active 13F managers last quarter, 4 opened and 8 added, while 9 reduced; the largest holder to move was BML Capital Management, LLC (+0.2%). No open-market insider trades in the last 180 days.

Tracked 13F holders
59
14 in Q2 2026 filings
13F value (tracked)
$38.4M
Smart-money readNeutral
Net sellingNet buying
Funds · active managers, latest 13F
12 adding · 9 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

No leg leans either way.

Price & smart-money activity

$1.40 2.78%5Y -95.1%
$0.78$8.61$16.45$24.28$32.122021202220232024202520269159201431419221429131722221522182142021201514192021117615320451116121511141634
Hover for who · click for detailEnd-of-day closing prices52w $1.02 – $1.80

Who owns PMVP?

59 tracked 13F filers · ranked by shares held

59 tracked 13F filers disclose a position in PMVP as of the latest SEC 13F filings, a combined $38.4M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1BML Capital Management, LLC5.3M
$7.1M
+0.2%
Added · +10K sh
Q2 2026
2Tang Capital Management LLC4.2M
$5.7M
Held
Q2 2026
3Euclidean Capital LLC2.6M
$3.5M
Held
Q2 2026
4Vanguard Capital Management LLC2.0M
$2.7M
+1.9%
Added · +37K sh
Q2 2026
5ArrowMark Colorado Holdings LLC2.0M
$2.6M
−32%
Reduced · −913K sh
Q2 2026
6Eversept Partners, LP1.9M
$2.5M
−19%
Reduced · −457K sh
Q2 2026
7Two Sigma Investments, LP1.9M
$2.3M
+167%
Added · +1.2M sh
Q1 2026
8Adage Capital Partners GP, L.L.C.1.9M
$2.3M
New
+1.9M sh
Q1 2026
9BlackRock, Inc.920K
$1.2M
+5.2%
Added · +45K sh
Q2 2026
10Morgan Stanley864K
$1.1M
+774%
Added · +765K sh
Q1 2026
11Longaeva Partners L.P.552K
$685K
New
+552K sh
Q1 2026
12Stonepine Capital Management, LLC536K
$718K
−24%
Reduced · −172K sh
Q2 2026
13Geode Capital Management, LLC473K
$635K
−4.6%
Reduced · −23K sh
Q2 2026
14Aldebaran Capital, LLC467K
$626K
−1.3%
Reduced · −6K sh
Q2 2026
15Marshall Wace, LLP434K
$538K
−6.7%
Reduced · −31K sh
Q1 2026
16Bridgeway Capital Management, LLC429K
$575K
Held
Q2 2026
17Walleye Capital LLC336K
$450K
Held
Q2 2026
18Vanguard Fiduciary Trust Co255K
$341K
−15%
Reduced · −43K sh
Q2 2026
19Bank Of America Corp241K
$298K
+0.2%
Added · +393 sh
Q1 2026
20ADAR1 Capital Management, LLC231K
$286K
+129%
Added · +130K sh
Q1 2026
21State Street Corp183K
$245K
Held
Q2 2026
22MAI Capital Management133K
$178K
New
+133K sh
Q2 2026
23Jane Street Group, LLC124K
$154K
−75%
Reduced · −375K sh
Q1 2026
24BIT Capital GmbH124K
$153K
New
+124K sh
Q1 2026
25Northern Trust Corp115K
$143K
−70%
Reduced · −267K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is PMVP being bought or sold by institutions?

Last quarter, 4 funds opened a new position in PMVP and 8 added to an existing one, while 9 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
4
funds took a first position
Added
8
added to an existing position
Reduced
9
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own PMVP also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA21 funds$14.8B
Amazon.com IncAMZN21 funds$10.5B
Eli Lilly & CoLLY21 funds$3.4B
JPMorgan Chase & CoJPM21 funds$3.2B
Bank Of America CorpBAC21 funds$1.3B
Microsoft CorpMSFT20 funds$8.4B
Advanced Micro DevicesAMD20 funds$3.6B
Pliant Therapeutics IncPLRX20 funds$24.3M
Meta Platforms Inc-Class AMETA19 funds$3.6B
Berkshire Hathaway Inc-CL BBRK/B19 funds$3.3B
Chevron CorpCVX19 funds$2.8B
Costco Wholesale CorpCOST19 funds$2.6B

Ranked by how many of PMVP's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in PMVP.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Oct 23, 2025OrbiMed Capital GP V LLC10% OwnerSell (S)1.0M$1.5M
Sep 10, 2025Orbimed Advisors Llc10% OwnerSell (S)500K$900K
Jul 1, 2025Mack David HenryPresident and CEO, DirectorSell (S)58K$62K
Jul 1, 2025Carulli MichaelChief Financial OfficerSell (S)28K$30K
Jul 1, 2025Jalota DeepikaChief Development OfficerSell (S)33K$35K
Jul 1, 2025Ticktin RobertGeneral Counsel & COOSell (S)23K$25K
Sep 11, 2024Carulli MichaelChief Financial OfficerSell (S)3K$4K
Sep 11, 2024Jalota DeepikaChief Development OfficerSell (S)7K$11K
Nov 22, 2023OrbiMed Genesis GP LLC10% OwnerSell (S)88K$196K
Sep 15, 2023Alland LeilaChief Medical OfficerSell (S)6K$42K
Sep 15, 2023Jalota DeepikaChief Development OfficerSell (S)4K$27K
May 26, 2022OrbiMed Capital GP V LLC10% OwnerSell (S)26K$418K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
1419
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
PMVP is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

14 tracked filers in Q2 2026 filingsstill filing
03059Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $12.0M
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for PMVP

Browse more

Build

Ask your agent what changed in PMVP

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/PMVP/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for PMVP.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PMVP. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.